The pattern of CD15, CD30 and Bcl-2 expression in diffuse large B-cell lymphoma

Medical Journal of Malaysia

Volumn 61, Issue 4, 2006, Pages 416-421

  Eow, G I ^a   Kim, L H ^a   Peh, S C ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Bcl 2; CD15; CD30; Diffuse large B cell lymphoma

Indexed keywords

CD15 ANTIGEN; CD30 ANTIGEN; PROTEIN BCL 2;

ADULT; ARTICLE; B CELL LYMPHOMA; CELL DIFFERENTIATION; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PROTEIN EXPRESSION; TUMOR CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD15; ANTIGENS, CD30; BCL-2-ASSOCIATED X PROTEIN; CHILD; FEMALE; GENES, BCL-2; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 33847047828     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, International Agency for Research on Cancer, 2001.
2. Peh SC, Shaminie J, Jayasurya P, Hiew J. Spectrum of malignant lymphoma in Queen Elizabeth Hospital, Sabah. Med J Malaysia 2003; 58: 546-55.
3. Chai SP, Peh SC, Kim LH, Lim MY, Gudum HR. The pattern of lymphoma in east Malaysia patients as experienced in the University Hospital, Kuala Lumpur. Malays J Pathol 1999; 21: 45-50.
4. Baars J, de Jong D, Willemse K et al. Diffuse large B-cell non- Hodgkin lymphomas: the clinical relevance of histological subclassification. Br J Cancer 1999; 79: 1770-76.
5. Salar A, Fernandez de Sevilla A, Ramagosa V et al. Diffuse large B-cell lymphoma: is morphologic subdivision useful in clinical management? Eur J Haematol 1998; 60: 202-8.
6. Haralambieva E, Pulford KA, Lamant L, et al. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas. Br J Haematol. 2000; 109: 584-91.
7. Hill ME, MacLennan KA, Cunningham DC, et al. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. Blood 1996; 88: 1046-51.
8. Peh SC, Kim LH, Thanaletchimy N, Chai SP. Spectrum of lymphomas from Klang General Hospital. Malays J Pathol 2000; 22: 13-20
9. Lim CC, Yahaya H, Lim TO. The first report of the national cancer registry: cancer incidence in Malaysia 2002: 166-9.
10. Sukpanichnant S. Analysis of 1983 Cases of Malignant Lymphoma in Thailand According to the World Health Organization Classification. Hum Pathol. 2004; 35: 224-30.
11. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005; 84: 1-12.
12. Chiu BC, Weisenburger DD. An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma. 2003; 4: 161-8.
13. Elgin J, Phillips JG, Reddy VV, Gibbs PO, Listinsky CM. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap. Ann Diagn Pathol 1999; 3: 263-75.
14. Sheibani K, Battifora H, Burke JS, Rappaport H. Leu-M1 antigen in human neoplasm. An immunohistologic study of 400 cases. Am J Surg Pathol 1986; 10: 227-36.
15. Laurence AL. Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu Rev Biochem 1995; 64: 113-39.
16. Lund-Johansen F, Olweus J, Horejsi V, et al. Activation of human phagocytes through carbohydrate antigens [CD15, sialyl-CD15, CDw17, and CDw65]. J Immunol 1992; 148: 3221-29.
17. Lo SK, Golenbock DT, Sass PM, Maskati A, Xu H, Silverstein RL. Engagement of the Lewis X antigen [CD15] results in monocyte activation. Blood 1997; 89: 307-14.
18. Abbondanzo SL, Sato N, Straus SE, Jaffe ES. Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations. Am J Clin Pathol 1990; 93: 698-702.
19. Skinnider BF, Horsman DE, Dupuis B, Gascoyne RD. Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. Hum Pathol 1999; 30: 803-8.
20. Villuendas R, Piris MA, Orradre JL, et al. Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa-associated lymphoid tissue. Am J Pathol 1991; 139: 989-93.
21. Rao PH, Houldsworth J, Dyomina K, et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood. 1998; 92: 234-40.